相关实验视频

Updated: Jan 17, 2026

Fabricating Superhydrophobic Polymeric Materials for Biomedical Applications
09:22

Fabricating Superhydrophobic Polymeric Materials for Biomedical Applications

Published on: August 28, 2015

19.7K

使用使用不同药品聚合物制备的电纳米纤维提高了probucol的可溶性和受控释放

Saki Arakawa1, Kouji Hara2,3, Yoko Koide2

  • 1Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University, Gifu, Japan.

Pharmaceutical development and technology
|September 22, 2025
PubMed
概括

使用特定的聚合物和表面活性剂,电改进了probucol (PRO) 的溶解性和释放性. 这项技术为开发可溶性较差化合物的先进药物输送系统提供了一个有前途的方法.

关键词:
电子旋转是一种电子旋转.有控制释放的释放.试试看这个问题.固体分散的固体分散表面活性剂是一种表面活性剂.

更多相关视频

Procedure for Fabricating Biofunctional Nanofibers09:39

Procedure for Fabricating Biofunctional Nanofibers

Published on: September 10, 2012

13.0K
Nanosponge Tunability in Size and Crosslinking Density11:15

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

8.0K

相关概念视频

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
223
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
673
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.6K